A Protocol for Generation of Clinical Grade mRNA‐Transfected Monocyte‐Derived Dendritic Cells for Cancer Vaccines
Open Access
- 3 November 2003
- journal article
- research article
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 58 (5), 578-586
- https://doi.org/10.1046/j.1365-3083.2003.01333.x
Abstract
With the aim of producing large quantities of mRNA-transfected monocyte-derived dendritic cells (DCs) to be used as cancer vaccines, a new clinical grade procedure has been developed. Peripheral bloo...Keywords
This publication has 25 references indexed in Scilit:
- The prognostic impact of cytokeratin‐positive cells in bone marrow of patients with localized prostate cancerInternational Journal of Cancer, 2002
- Comparison of monocyte enrichment by immuno-magnetic depletion or adherence for the clinical-scale generation of DCCytotherapy, 2001
- Dendritic cell elimination as an assay of cytotoxic T lymphocyte activity in vivoJournal of Immunological Methods, 2000
- Dendritic Cells Capture Killed Tumor Cells and Present Their Antigens to Elicit Tumor-Specific Immune ResponsesThe Journal of Immunology, 2000
- Human Dendritic Cells Transfected with RNA Encoding Prostate-Specific Antigen Stimulate Prostate-Specific CTL Responses In VitroThe Journal of Immunology, 2000
- Dendritic cells and the control of immunityNature, 1998
- Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cellsNature Medicine, 1998
- Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo.The Journal of Experimental Medicine, 1996
- Proliferating dendritic cell progenitors in human blood.The Journal of Experimental Medicine, 1994
- The Dendritic Cell System And Its Role In ImmunogenicityAnnual Review of Immunology, 1991